S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7142 +0.01%
AFTER HRS · 18:10 ET
Market ClerkRecap
Fri Oct 23 · after hours6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

PBM

PSYENCE BIOMEDICAL LTD.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
4.16
+0.05 +1.09%
USD · close Oct 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose PBM in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Psyence Labs Ltd.49.8%
SCHEDULE 13D/A · filed Oct 15 · investment · EDGAR ↗

“Item 4 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: The Reporting Person acquired the Subject Shares pursuant to the exercise of an irrevocable put option granted to the Reporting Person under the Put Option Agreement, as previously disclosed in the Origina…”

AdvisorShares Trust6.8%
SCHEDULE 13G · filed Oct 5 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch PBM. Know when insiders buy.
One email the day a filing lands. Free.